Outcomes of Hypofractional Tomotherapy in Patients with Stage III Nonsmall Cell Lung Cancer Who Are Not Eligible for Surgery or Concurrent Chemoradiation

PURPOSE: We assessed the clinical outcomes and toxicities following hypofractionation with helical tomographic intensity-modulated radiotherapy technology (tomotherapy) in patients with stage III non-small cell lung cancer (NSCLC) who were not candidates for surgery or concurrent chemoradiation. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jing, Li, Hongqi, Wang, Yingjie, Liu, Junyang, Wang, Xuan, Pang, Haifeng, Chang, Dongshu, Di, Yupeng, Ren, Gang, Li, Ping, Wang, Yong, Liu, Chen, Chen, Xiao, Kang, Xiaoli, Xia, Tingyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345954/
https://www.ncbi.nlm.nih.gov/pubmed/32685544
http://dx.doi.org/10.1155/2020/9168424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345954/
https://www.ncbi.nlm.nih.gov/pubmed/32685544
http://dx.doi.org/10.1155/2020/9168424

Ejemplares similares